Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy. - Schneider M; Paruzzo L; Stella F; Noll JH; Ho M; Babatunde V; Ho B; Devi P; Chong EA; Barta SK; Nasta SD; Svoboda J; et al. (Nature communications, 2026)